Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review

• Published in: Pharmaceuticals (Basel, Switzerland) Vol. 14; no. 9; p. 903
• Main Authors: Zabidi, Mohd Shafie, Abu Bakar, Ruzilawati, Musa, Nurfadhlina, Mustafa, Suzana, Wan Yusuf, Wan Nazirah
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 06.09.2021; MDPI
• Subjects: Aerosols; colistin; colistin methanesulfonate sodium; Critical care; critically ill patients; Intensive care; Patients; Pharmacokinetics; Plasma; Pneumonia; Population; population pharmacokinetics; Review; Sodium; Systematic review; therapeutic drug monitoring; United States > US
• ISSN: 1424-8247; 1424-8247
• DOI: 10.3390/ph14090903

Understanding the pharmacokinetics parameter of colistin methanesulfonate sodium (CMS) and colistin is needed to optimize the dosage regimen in critically ill patients. However, there is a scarcity of pharmacokinetics parameters in this population. This review provides a comprehensive understanding of CMS and colistin pharmacokinetics parameters in this population. The relevant studies published in English that reported on the pharmacokinetics of CMS and colistin from 2000 until 2020 were systematically searched using the PubMed and Scopus electronic databases. Reference lists of articles were reviewed to identify additional studies. A total of 252 citation titles were identified, of which 101 potentially relevant abstracts were screened, and 25 full-text articles were selected for detailed analysis. Of those, 15 studies were included for the review. This review has demonstrated vast inter-study discrepancies in colistin plasma concentration and the pharmacokinetics parameter estimates. The discrepancies might be due to complex pathophysiological changes in the population studied, differences in CMS brand used, methodology, and study protocol. Application of loading dose of CMS and an additional dose of CMS after dialysis session was recommended by some studies. In view of inter-patient and intra-patient variability in colistin plasma concentration and pharmacokinetics parameters, personalized colistin dosing for this population is recommended.